Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.

Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Mar 11, 2024
Document Date
Mar 11, 2024
Form Description
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
Filing Group
Other
Company
Vericel Corporation
Issuer
VERICEL CORP

NASDAQ: VCEL

$57.61 +0.11 (+0.19%)
Day High: $58.76
Day Low: $57.03
Volume: 316,765
4:00 PM EST on
Jan 6, 2025
Data Provided by Refinitiv. Minimum 15 minutes delayed.